Device therapy in heart failure: Has CRT changed "the sickest benefit the most" to "the healthiest benefit the most?"

Journal of the American College of Cardiology

Volumn 61, Issue 9, 2013, Pages 945-947

  Gasparini, Maurizio ^a   Galimberti, Paola ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

cardiac resynchronization therapy; heart failure; implantable cardioverter defibrillator; left ventricular ejection fraction

Indexed keywords

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; DEVICE THERAPY; DISEASE SEVERITY; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MORTALITY; NOTE; PATIENT CODING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REMISSION; THERAPY EFFECT;

EID: 84875429708     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.048     Document Type: Editorial

References (10)

1. V. Kutyifa, A. Kloppe, W. Zareba The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) J Am Coll Cardiol 61 2013 936 944
2. A. Auricchio, C. Stellbrink, S. Sack Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay J Am Coll Cardiol 39 2002 2026 2033
3. G.S. Nelson, R.D. Berger, B.J. Fetics Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block Circulation 19 2000 3053 3059
4. C. Linde, W.T. Abraham, M.R. Gold, M. St. John Sutton, S. Ghio, C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol 52 2008 1834-3
5. A.J. Moss, W.J. Hall, D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
6. A.S.L. Tang, G.A. Wells, M. Talajic Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
7. M. Gasparini, F. Regoli, C. Ceriotti Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy: temporal pattern and clinical predictors Am Heart J 155 2008 507 514
8. A.J. Moss Implantable cardioverter defibrillator therapy: the sickest benefit the most Circulation 101 2000 1638 1640
9. J.J. McMurray, S. Adamopoulos, S.D. Anker ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
10. C.M. Tracy, A.E. Epstein, D. Darbar 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities J Am Coll Cardiol 60 2012 1297 1313